Literature DB >> 25762139

Cancer immunotherapy: dendritic-cell vaccines on the move.

Rachel Lubong Sabado1, Nina Bhardwaj1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25762139     DOI： 10.1038/nature14211

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  17 in total

Review 1.  Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression.

Authors:  F Sallusto; A Lanzavecchia
Journal:  Immunol Rev       Date:  2000-10       Impact factor: 12.988

2.  Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming.

Authors:  Rhys S Allan; Jason Waithman; Sammy Bedoui; Claerwen M Jones; Jose A Villadangos; Yifan Zhan; Andrew M Lew; Ken Shortman; William R Heath; Francis R Carbone
Journal:  Immunity       Date:  2006-07       Impact factor: 31.745

Review 3.  Macrophage inflammatory protein-1.

Authors:  Patricia Menten; Anja Wuyts; Jo Van Damme
Journal:  Cytokine Growth Factor Rev       Date:  2002-12       Impact factor: 7.638

Review 4.  Chemokines and chemokine receptors: positioning cells for host defense and immunity.

Authors:  Jason W Griffith; Caroline L Sokol; Andrew D Luster
Journal:  Annu Rev Immunol       Date:  2014       Impact factor: 28.527

5.  Regulatory T cells target chemokine secretion by dendritic cells independently of their capacity to regulate T cell proliferation.

Authors:  Sara Morlacchi; Valentina Dal Secco; Cristiana Soldani; Nicolas Glaichenhaus; Antonella Viola; Adelaida Sarukhan
Journal:  J Immunol       Date:  2011-05-13       Impact factor: 5.422

Review 6.  Chemokines as regulators of T cell differentiation.

Authors:  S A Luther; J G Cyster
Journal:  Nat Immunol       Date:  2001-02       Impact factor: 25.606

Review 7.  Dendritic-cell-based therapeutic cancer vaccines.

Authors:  Karolina Palucka; Jacques Banchereau
Journal:  Immunity       Date:  2013-07-25       Impact factor: 31.745

8.  Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming.

Authors:  Alfonso MartIn-Fontecha; Silvia Sebastiani; Uta E Höpken; Mariagrazia Uguccioni; Martin Lipp; Antonio Lanzavecchia; Federica Sallusto
Journal:  J Exp Med       Date:  2003-08-18       Impact factor: 14.307

9.  Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients.

Authors:  Duane A Mitchell; Kristen A Batich; Michael D Gunn; Min-Nung Huang; Luis Sanchez-Perez; Smita K Nair; Kendra L Congdon; Elizabeth A Reap; Gary E Archer; Annick Desjardins; Allan H Friedman; Henry S Friedman; James E Herndon; April Coan; Roger E McLendon; David A Reardon; James J Vredenburgh; Darell D Bigner; John H Sampson
Journal:  Nature       Date:  2015-03-11       Impact factor: 49.962

10.  Immunological targeting of cytomegalovirus for glioblastoma therapy.

Authors:  Smita K Nair; John H Sampson; Duane A Mitchell
Journal:  Oncoimmunology       Date:  2014-06-25       Impact factor: 8.110
View more
  31 in total

1.  Uncovering the underlying mechanism of cancer tumorigenesis and development under an immune microenvironment from global quantification of the landscape.

Authors:  Li Wenbo; Jin Wang
Journal:  J R Soc Interface       Date:  2017-06       Impact factor: 4.118

Review 2.  Tissue-resident dendritic cells and diseases involving dendritic cell malfunction.

Authors:  Keqiang Chen; Ji Ming Wang; Ruoxi Yuan; Xiang Yi; Liangzhu Li; Wanghua Gong; Tianshu Yang; Liwu Li; Shaobo Su
Journal:  Int Immunopharmacol       Date:  2016-02-22       Impact factor: 4.932

3.  Collagen I enhances the efficiency and anti-tumor activity of dendritic-tumor fusion cells.

Authors:  Jian He; Rong Zheng; Zhenghua Zhang; Jie Tan; Chaofan Zhou; Guoqing Zhang; Xinglu Jiang; Qianyi Sun; Sufang Zhou; Duo Zheng; Yong Huang; Lige Wu; Zongqiang Lai; Jieping Li; Nuo Yang; Xiaoling Lu; Yongxiang Zhao
Journal:  Oncoimmunology       Date:  2017-08-08       Impact factor: 8.110

Review 4.  Engineering challenges for brain tumor immunotherapy.

Authors:  Johnathan G Lyon; Nassir Mokarram; Tarun Saxena; Sheridan L Carroll; Ravi V Bellamkonda
Journal:  Adv Drug Deliv Rev       Date:  2017-06-15       Impact factor: 15.470

5.  Dying glioma cells establish a proangiogenic microenvironment through a caspase 3 dependent mechanism.

Authors:  Xiao Feng; Yang Yu; Sijia He; Jin Cheng; Yanping Gong; Zhengxiang Zhang; Xuguang Yang; Bing Xu; Xinjian Liu; Chuan-Yuan Li; Ling Tian; Qian Huang
Journal:  Cancer Lett       Date:  2016-11-05       Impact factor: 8.679

6.  Inflammation-Triggered Cancer Immunotherapy by Programmed Delivery of CpG and Anti-PD1 Antibody.

Authors:  Chao Wang; Wujin Sun; Grace Wright; Andrew Z Wang; Zhen Gu
Journal:  Adv Mater       Date:  2016-08-25       Impact factor: 30.849

Review 7.  Nanomedicine and Onco-Immunotherapy: From the Bench to Bedside to Biomarkers.

Authors:  Vanessa Acebes-Fernández; Alicia Landeria-Viñuela; Pablo Juanes-Velasco; Angela-Patricia Hernández; Andrea Otazo-Perez; Raúl Manzano-Román; Rafael Gongora; Manuel Fuentes
Journal:  Nanomaterials (Basel)       Date:  2020-06-29       Impact factor: 5.076

Review 8.  Stromal contributions to the carcinogenic process.

Authors:  Mark Spaw; Shrikant Anant; Sufi Mary Thomas
Journal:  Mol Carcinog       Date:  2016-11-05       Impact factor: 4.784

9.  Dual activation of Toll-like receptors 7 and 9 impairs the efficacy of antitumor vaccines in murine models of metastatic breast cancer.

Authors:  Mariela A Moreno Ayala; María Florencia Gottardo; María Soledad Gori; Alejandro Javier Nicola Candia; Carla Caruso; Andrea De Laurentiis; Mercedes Imsen; Slobodanka Klein; Elisa Bal de Kier Joffé; Gabriela Salamone; Maria G Castro; Adriana Seilicovich; Marianela Candolfi
Journal:  J Cancer Res Clin Oncol       Date:  2017-04-21       Impact factor: 4.553

Review 10.  Dendritic cells based immunotherapy.

Authors:  Na Shang; Matteo Figini; Junjie Shangguan; Bin Wang; Chong Sun; Liang Pan; Quanhong Ma; Zhuoli Zhang
Journal:  Am J Cancer Res       Date:  2017-10-01       Impact factor: 6.166
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.